Key Record Dates
ClinicalTrials.gov Identifier: | NCT03502577 |
---|---|
Brief Title: | BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma |
First Submitted : | April 11, 2018 |
First Submitted that Met QC Criteria : | April 11, 2018 |
First Posted : | April 18, 2018 |
Last Update Submitted that Met QC Criteria : | January 4, 2024 |
Last Update Posted : | January 8, 2024 |